๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects

โœ Scribed by R. Paroni; I. Fermo; P. Fiorina; G. Cighetti

Publisher
Springer
Year
2005
Tongue
English
Weight
91 KB
Volume
28
Category
Article
ISSN
0939-4451

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Determination of Arginine, Asymmetric Di
Determination of Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma and Other Biological Samples by High-Performance Liquid Chromatography
โœ Tom Teerlink; Robert J. Nijveldt; Sigrid de Jong; Paul A.M. van Leeuwen ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 74 KB

Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), may be related to reduced biosynthesis of nitric oxide in diseases associated with accelerated atherosclerosis. The closely related compound symmetric dimethylarginine (SDMA) does not inhibit NOS, but may com

Serum concentrations of asymmetric (ADMA
Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients
โœ Fleck, Christian; Janz, Alexander; Schweitzer, Frank; Karge, Elke; Schwertfeger, ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 813 KB

## Background: Nitric oxide (no) synthesis is inhibited by the adma that accumulates in the plasma of patients with renal failure; however, the concentration of sdma also is enhanced. therefore, it has been hypothesized that adma and sdma may contribute to hypertension in these patients. ## Method

Determination of arginine and asymmetric
Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique
โœ Jens Martens-Lobenhoffer; Olga Krug; Stefanie M. Bode-Bรถger ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Abstract Arginine (ARG) is a substrate for endogenous nitric oxide (NO) production whereas its metabolite, asymmetric dimethylarginine (ADMA), acts as an inhibitor. Sufficient NO production is essential for cardiovascular key functions, thus elevated concentration levels of ADMA are related to a